3,722 Shares in Corteva, Inc. $CTVA Purchased by Trust Investment Advisors

Trust Investment Advisors bought a new position in shares of Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, Holdings Channel.com reports. The firm bought 3,722 shares of the company’s stock, valued at approximately $277,000.

Other institutional investors have also recently made changes to their positions in the company. Peak Financial Advisors LLC purchased a new stake in shares of Corteva during the second quarter worth about $505,000. Cary Street Partners Financial LLC grew its position in shares of Corteva by 20.7% during the first quarter. Cary Street Partners Financial LLC now owns 90,206 shares of the company’s stock worth $5,677,000 after purchasing an additional 15,448 shares in the last quarter. PGGM Investments grew its position in shares of Corteva by 68.5% during the second quarter. PGGM Investments now owns 1,223,444 shares of the company’s stock worth $91,183,000 after purchasing an additional 497,200 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of Corteva by 28.6% during the first quarter. Goldman Sachs Group Inc. now owns 2,851,993 shares of the company’s stock worth $179,476,000 after purchasing an additional 634,938 shares in the last quarter. Finally, S.E.E.D. Planning Group LLC grew its position in shares of Corteva by 70.3% during the second quarter. S.E.E.D. Planning Group LLC now owns 164,393 shares of the company’s stock worth $12,252,000 after purchasing an additional 67,869 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on CTVA shares. UBS Group cut their target price on Corteva from $91.00 to $85.00 and set a “buy” rating for the company in a research report on Monday, October 6th. Jefferies Financial Group cut their price target on Corteva from $92.00 to $85.00 in a report on Thursday, October 2nd. Zacks Research upgraded Corteva from a “hold” rating to a “strong-buy” rating in a report on Wednesday, October 1st. Mizuho cut their price target on Corteva from $85.00 to $78.00 and set an “outperform” rating for the company in a report on Wednesday, October 8th. Finally, Wells Fargo & Company cut their price target on Corteva from $83.00 to $80.00 and set an “overweight” rating for the company in a report on Thursday, October 16th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $79.94.

Insider Activity

In other news, EVP Robert D. King sold 37,280 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $74.20, for a total value of $2,766,176.00. Following the completion of the sale, the executive vice president directly owned 49,262 shares of the company’s stock, valued at $3,655,240.40. This trade represents a 43.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.14% of the stock is owned by insiders.

Corteva Price Performance

NYSE:CTVA opened at $63.89 on Tuesday. The firm has a market capitalization of $43.39 billion, a price-to-earnings ratio of 31.16, a PEG ratio of 1.46 and a beta of 0.76. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $77.41. The business has a 50 day simple moving average of $68.36 and a 200-day simple moving average of $69.24. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.68 and a quick ratio of 1.23.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $2.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.89 by $0.31. The business had revenue of $6.46 billion during the quarter, compared to analyst estimates of $6.26 billion. Corteva had a return on equity of 8.68% and a net margin of 8.16%.The company’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same period last year, the company earned $1.83 EPS. Equities analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.